| Psoriatic Arthritis |
1 |
1 |
| Psoriasis |
0 |
0.9 |
| Biologic Therapy |
0 |
0.67 |
| Asthma |
0 |
0.48 |
| Nail Psoriasis |
0 |
0.42 |
| Arthritis |
0 |
0.39 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.39 |
| Plaque Psoriasis |
0 |
0.39 |
| Severe Asthma |
0 |
0.39 |
| Humanized Monoclonal Antibody |
0 |
0.28 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.23 |
| Dementia |
0 |
0.2 |
| Europe |
0 |
0.2 |
| Fatigue |
0 |
0.2 |
| Food and Drug Administration (FDA) |
0 |
0.2 |
| Glucocorticoid |
0 |
0.2 |
| Hospital |
0 |
0.2 |
| Interleukin |
0 |
0.2 |
| Monoclonal Antibody |
0 |
0.2 |
| Nail |
0 |
0.2 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.2 |
| Phototherapy |
0 |
0.2 |
| Rheumatic Disease |
0 |
0.2 |
| Texas |
0 |
0.2 |